Evidence-based medicine and clinical practice in octogenarians: The management of hypercholesterolemia;Evidencia científica y práctica clínica en octogenarios: A propósito del manejo de la hipercolesterolemia

Revista Espanola de Geriatria y Gerontologia

Volumn 50, Issue 2, 2015, Pages 49-50

  Baztán, Juan José ^a   Formiga, Francesc ^b  

^a HOSPITAL CENTRAL DE LA CRUZ ROJA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HEALTH CARE MANAGEMENT; HUMAN; HYPERCHOLESTEROLEMIA; VERY ELDERLY;

AGED, 80 AND OVER; EVIDENCE-BASED MEDICINE; HUMANS; HYPERCHOLESTEROLEMIA;

EID: 84924332909     PISSN: 0211139X     EISSN: 15781747     Source Type: Journal    
DOI: 10.1016/j.regg.2014.10.006     Document Type: Article

References (20)

1. Instituto Nacional de Estadística. Proyecciones de población a largo plazo [consultado 1 Oct 2014]. Disponible en: . http://www.ine.es/prensa/np744.pdf.
2. Instituto Nacional de Estadística. Defunciones según causa de muerte [consultado 1 Oct 2014]. Disponible en: . http://www.ine.es/prensa/np830.pdf.
3. Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2163-2196.
4. Gómez-Huelgas R., Martínez-Sellés M., Formiga F., Alemán J.J., Camafort M., Galve E., et al. Tratamiento de los factores de riesgo vascular en el paciente mayor de 80 años. Med Clin (Barc) 2014, 143:134e1-134e11.
5. Félix-Redondo F.J., Grau M., Fernández-Bergés D. Cholesterol and cardiovascular disease in the elderly. Facts and gaps. Aging Dis 2013, 4:154-169.
6. Strandberg T.E., Kolehmainen L., Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: A clinical review. JAMA 2014, 312:1136-1144.
7. Bulpitt C.J. Secondary prevention of coronary heart disease in the elderly. Heart 2005, 91:396-400.
8. Instituto Nacional de Estadística. Encuesta de Discapacidad, Autonomía Personal y Situaciones de Dependencia 2008 [consultado 1 Oct 2014]. Disponible en: . http://www.ine.es/inebmenu/mnu_salud.htm.
9. Gómez Huelgas R., Díez-Espino J., Formiga F., Lafita Tejedor J., Rodríguez Mañas L., González-Sarmiento E., et al. Tratamiento de la diabetes tipo 2 en el paciente anciano. Documento de consenso. Med Clin (Barc) 2013, 140:134. e1-12.
10. Guallar-Castillón P., Gil-Montero M., León-Muñoz L.M., Graciani A., Bayán-Bravo A., Taboada J.M., et al. Magnitude and management of hypercholesterolemia in the adult population of Spain, 2008-2010: The ENRICA Study. Rev Esp Cardiol (Engl Ed) 2012, 65:551-558.
11. Chokshi N.P., Messerli F.H., Sutin D., Supariwala A.A., Shah N.R. Appropriateness of statins in patients aged ≥80 years and comparison to other age groups. Am J Cardiol 2012, 110:1477-1481.
12. Brugts J.J., Yetgin T., Hoeks S.E., Gotto A.M., Shepherd J., Westendorp R.G., et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: Meta-analysis of randomised controlled trials. BMJ 2009, 338:b2376.
13. Savarese G., Gotto A.M., Paolillo S., D'Amore C., Losco T., Musella F., et al. Benefits of statins in elderly subjects without established cardiovascular disease: A metaanalysis. J Am Coll Cardiol 2013, 62:2090-2099.
14. Petersen L.K., Christensen K., Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80±year olds. Age Ageing 2010, 39:674-680.
15. Morley J.E. The cholesterol conundrum. J Am Griatr Soc 2011, 59:1955-1956.
16. STAREE Study Investigators. A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE). Clinical Trials.gov website [consultado 1 Oct 2014]. http://clinicaltrials.gov/show/NCT02099123.
17. Stone N.J., Robinson J.G., Lichtenstein A.H., Bairey Merz C.N., Blum C.B., Eckel R.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129(Suppl 2):S1-S45. American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
18. Dumurgier J., Singh-Manoux A., Tavernier B., Tzourio C., Elbaz A. Lipid-lowering drugs associated with slower motor decline in the elderly adults. J Gerontol A Biol Sci Med Sci 2014, 69:199-206.
19. Desai C.S., Martin S.S., Blumenthal R.S. Non-cardiovascular effects associated with statins. BMJ. 2014, 349:g3743.
20. Padala K.P., Padala P.R., McNeilly D.P., Geske J.A., Sullivan D.H., Potter J.F. The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: A prospective withdrawal and rechallenge pilot study. Am J Geriatr Pharmacother 2012, 10:296-302.